Background: We report on the characteristics and determinants of outcome of the 35784 pts included in the nationwide NETSARC/RREPS study since its inception. Methods: NETSARC (netsarc.org) is a network of 26 reference sarcoma centers with specialized multidisciplinary tumor boards (MDTB), funded by the French National Cancer Institute to improve the outcome of sarcoma patients. Since 2010, presentation to an MDTB and second pathological review are mandatory for sarcoma patients. Patients' characteristics and follow-up are collected in a database regularly monitored. Descriptive, uni and multivariate analysis of prognostic factors were conducted in the incident (n ¼ 29497) pts population as well as on pts diagnosed before 1/1/2010 (n ¼ 6287), presented to an MDTB after 1/1/10. Results: We first investigated predisposing and associated conditions: among the 35784, previous cancer, previous RT, NF1, Li-Fraumeni, were reported in 12.5%, 3.6%, 0.7%, 0.1% of pts respectively. 71 of the 35784 (0.2%) pts had 2 or 3 different diagnosis of sarcomas: 28%, 7%, 6%, 3% of these pts had an history of previous cancer, NF1, Li-Fraumeni, Ollier disease (p < 0.001). Prognostic factors of pts outcome at initial diagnosis were then analyzed: male gender, age, size, depth, grade 3, NF1, previous RT were all associated with a worse overall (OS) and progression free survival (PFS) in the incident pts population in univariate and multivariate analysis, while GIST, intermediate malignancy histologies, and surgery in a Netsarc center (HR:0,63) were positively correlated with OS and PFS (p < 0.001 for all). Similar results were obtained in the 6287 pts diagnosed before 2010 for OS. In pts in advanced phase, survival was superior to that reported in the literature with a median of 27 months for all sarcomas but GIST. Median OS was not reached for GIST and tumor of intermediate malignancy (58% and 76% at 5 years respectively). NF1, previous RT, and treatment outside a reference center were again associated with a worse OS in multivariate analysis. Conclusions: In this nationwide registry of sarcoma patients, unreported prognostic characteristics sarcoma pts were identified.Treatment in a reference center reduces the risk of relapse and death.
Background: Misdiagnosis of soft tissue sarcoma (STS) is common, due to their rarity and unclear clinical presentation. As a result, unplanned excisions (UE) may occur, most often necessitating further treatment at specialised tumour centres. Therapy includes re-resection and adjuvant radiotherapy (ARTX), being associated with increased morbidity. Results on UE's impact on overall survival (OS) are contradictory, though. Methods: 728 STS patients (376 male, 352 female; mean age: 58 years) undergoing primary surgery or re-resection following UE at three tumour centres were retrospectively included. Median follow-up was 5.5 years. Differences between UE-and non-UEpatients were analysed using chi-square and t-tests. Log-rank and Gray's tests were applied for time-to-event analyses. Based on differences between UE-and non-UEpatients at baseline, a propensity score of being in the UE-group was estimated. Based on the propensity score, an inverse-probability-of-UE-weight (IPUEW) was calculated. This allowed re-calculation of time-to-event analyses following adjustment for imbalances between non-UE-and UE-patients. Results: UE had been performed in 281 patients (38.6%), with similar incidences at the three tumour centres. Small (p < 0.005) and superficially located STS (p < 0.005) with a long history of symptoms (p < 0.005), male gender (p ¼ 0.05) and young age (p ¼ 0.036) raised the risk of an UE being performed. At re-resection, plastic reconstruction (p < 0.005) and ARTX (p ¼ 0.041) were significantly more common in UEpatients. In the univariate analysis, UE-patients had a significantly better OS (5-/10year OS: 78.6%/63.3% for UE; 70.6%/57.9% for non-UE; p ¼ 0.028). Due to a strong correlation between positive prognostic factors and a prior UE, survival analyses were re-calculated after weighting for the IPUEW. As a result, the prognostic benefit of UE in terms of OS was lost (p ¼ 0.241). Conclusions: Morbidity is raised in patients following UE due to increased necessity of plastic reconstruction and ARTX. However, there is no direct impact of UE on OS. Nevertheless, it is arguable whether a more aggressive approach in the UE-group compensates for the inappropriate primary resection. Thus, UE must be avoided by all means.
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